Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature - Archive ouverte HAL Access content directly
Journal Articles ESMO Open Year : 2021

Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature

K. Hodroj
  • Function : Author
D. Barthelemy
  • Function : Author
J.-C. Lega
  • Function : Author
G. Grenet
  • Function : Author
M.-C. Gagnieu
  • Function : Author
J. Guitton
  • Function : Author
L. Payen-Gay
  • Function : Author

Dates and versions

hal-04492195 , version 1 (06-03-2024)

Licence

Attribution - NonCommercial - NoDerivatives

Identifiers

Cite

K. Hodroj, D. Barthelemy, J.-C. Lega, G. Grenet, M.-C. Gagnieu, et al.. Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature. ESMO Open, 2021, 6 (3), pp.100125. ⟨10.1016/j.esmoop.2021.100125⟩. ⟨hal-04492195⟩
4 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More